Recent Studies of QSAR on Inhibitors of Estrogen Receptor and Human Eosinophil Phosphodiesterase

E-ISSN： 1875-6697|5|3|200-214

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.5, Iss.3, 2009-09, pp. : 200-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors

By Chakraborti A.K. Gopalakrishnan B. Sobhia M.E. Malde A.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 11, 2003-11 ,pp. : 975-982

Elsevier

Access to resources Recommend Favorite

Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors

By Ezeamuzie C.I.

European Journal of Pharmacology, Vol. 417, Iss. 1, 2001-04 ,pp. : 11-18

Elsevier

Access to resources Recommend Favorite

QSAR Studies of PTP1B Inhibitors: Recent Advances and Perspectives

Current Medicinal Chemistry, Vol. 19, Iss. 25, 2012-09 ,pp. : 4208-4217

Bentham Science Publishers

Access to resources Recommend Favorite

3D QSAR Pharmacophore, CoMFA and CoMSIA Based Design and Docking Studies on Phenyl Alkyl Ketones as Inhibitors of Phosphodiesterase 4

Medicinal Chemistry, Vol. 8, Iss. 5, 2012-09 ,pp. : 894-912

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR of Novel Phosphodiesterase-4 Inhibitors by Genetic Function Approximation

Medicinal Chemistry, Vol. 7, Iss. 6, 2011-11 ,pp. : 543-552

Bentham Science Publishers

Access to resources Recommend Favorite